During the Miami Breast Cancer Conference, CURE discussed ADCs with Dr. Kevin Kalinsky.
Dr. Kevin Kalinsky
Advertisement
Articles by Dr. Kevin Kalinsky
Dr. Kevin Kalinsky discusses common side effects associated with the FDA-approved combination of Enhertu and Perjeta for breast cancer.
Dr. Kevin Kalinsky discusses the role of targeted therapy and clinical decision-making in managing estrogen-driven, HER2-negative breast cancer.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
Top 5 Takeaways From ASCO 2026 That Patients Should Know
2
Lynch Syndrome: Why Upper Endoscopies and Colonoscopy Prep Save My Life
3
Iza-Bren Improves Survival in Metastatic Triple-Negative Breast Cancer
4
How a Teen Cancer Survivor and Her Best Friend Created an App to Help Patients Between Appointments
5